Table 1.
Clinical characteristics and descriptive statistics of cohort.
| Spalte1 | n | Percentage | Mean | Range | SD |
|---|---|---|---|---|---|
| Age | 40 | 21.5 years | 4–62 years | 13.54 years | |
| Sex | |||||
| Male | 28 | 70% | - | - | - |
| Female | 12 | 30% | - | - | - |
| Site | |||||
| Femur | 11 | 27.50% | - | - | - |
| Tibia | 8 | 20% | - | - | - |
| Humerus | 2 | 5% | - | - | - |
| Clavicula | 2 | 5% | - | - | - |
| Radius | 2 | 5% | - | - | - |
| Hip | 8 | 20% | - | - | - |
| Foot | 2 | 5% | - | - | - |
| Spine | 1 | 2.50% | - | - | - |
| Multifocal | 4 | 10% | - | - | - |
| Follow-up | |||||
| DOD | 17 | 42.50% | - | - | - |
| NED | 21 | 52.50% | - | - | - |
| AWD | 2 | 5% | - | - | - |
| Metastasis | |||||
| Pulmonary | 7 | 17.50% | - | - | - |
| Skeletal | 2 | 5% | - | - | - |
| Multifocal | 10 | 25% | - | - | - |
| At diagnosis | 15 | 37.50% | - | - | - |
| None | 6 | 15% | |||
| Local recurrence | 6 | 15% | - | - | - |
| DFS | 40 | - | 3.5 years | 0–17 years | 54.5 years |
| Follow-up | 40 | - | 4.79 years | 0–17 years | 53.6 years |
| CRP | |||||
| >0.5 mg/dL | 27 | 67.50% | 1.6 mg/dL | 0.6–32.8 mg/dL | 9 mg/dL |
| <0.5 md/dL | 13 | 32. 50% | 0.1 mg/dL | 0.1–0.2 mg/dL | 0.05 mg/dL |